Latest Breaking News On - Marina corleto - Page 1 : comparemela.com

Forge Biologics Reports Positive FBX-101 Clinical Updates for Patients with Krabbe Disease at WORLDSymposium

Data from the RESKUE Phase 1/2 clinical trial continues to demonstrate safety and efficacy post-FBX-101 systemic administration in patients recently receiving hematopoietic stem cell transplantation

United statesDennis riedlMarina corletoMagdalena tyrpienBrain developmentUniversity of michigan medical centerHead of business developmentBusiness developmentMaria escolarChief medical officerMichigan medicalForge biologicsBusiness wireHuman phaseSupports brain developmentImproves motor function

Forge Biologics Receives Priority Medicines (PRIME) Designation from the European Medicines Agency (EMA) for Novel Gene Therapy FBX-101 for the Treatment of Patients with Krabbe Disease

FBX-101 is granted priority medicines (PRIME) designation by the European Medicines Agency (EMA) after review of Phase 1/2 RESKUE clinical trial safety and efficacy data PRIME designation

United statesKostenloser wertpapierhandelMarina corletoMagdalena tyrpienEuropean society of gene cell therapyRegulatory affairsEuropean medicines agencyHead of business developmentBusiness developmentChristopher shillingSenior vice presidentMaria escolarChief medical officerInborn errorsAnnual symposiumEuropean society

Forge Biologics Announces Updated Positive Clinical Data in RESKUE, a Novel Phase 1/2 Gene Therapy Trial for Patients with Krabbe Disease

Forge Biologics Announces Updated Positive Clinical Data in RESKUE, a Novel Phase 1/2 Gene Therapy Trial for Patients with Krabbe Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomCity ofTimothyj millerMarina corletoChristina perryMagdalena tyrpienEuropean society of gene cell therapyAlliance for regenerative medicineHead of business developmentBusiness developmentChief medical officer maria escolarEuropean societyCell therapyRegenerative medicineGene meeting

Forge Biologics to Present and Participate at Upcoming Investor Conferences

Forge Biologics to Present and Participate at Upcoming Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTimothyj millerMarina corletoChristina perryCompany eventsSecurities biopharma private companySenior vice presidentInvestor relationsBiopharma private company connectVice president

Forge Biologics Fuels Gene Therapy Manufacturing Engine with Launch of Plasmid DNA Manufacturing Services to Support AAV Clients

Enables gene therapy clients to accelerate AAV manufacturing with seamless incorporation into the Company's HEK 293 platform suspension process with access to end-to-end capabilities New offerings

United statesSteven weselKostenloser wertpapierhandelDonald belcherFrank agbogboJohn maslowskiMarina corletoGanesh krishnamoorthyBioprocess international conference exhibitionBioprocess internationalClient developmentBioprocess international eastChief commercial officerProcess developmentSingle use fermentersVice president